{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:05:10Z","timestamp":1791666310415,"version":"4.3.4"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000952","name":"Paul G. Allen Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000952","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the UNDP (United Nations Development Program)\u2013UNFPA (United Nations Population Fund)\u2013UNICEF\u2013WHO\u2013World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP),"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Sexual transmission chains of Ebola virus (EBOV) have been verified and linked to EBOV RNA persistence in semen, post-recovery. The rate of semen persistence over time, including the average duration of persistence among Ebola virus disease (EVD) survivors, is not well known. This cohort study aimed to analyze population estimates of EBOV RNA persistence rates in semen over time, and associated risk factors in a population of survivors from Sierra Leone.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>In this cohort study from May 2015 to April 2017 in Sierra Leone, recruitment was conducted in 2 phases; the first enrolled 100 male participants from the Western Area District in the capital of Freetown, and the second enrolled 120 men from the Western Area District and from Lungi, Port Loko District. Mean age of participants was 31 years. The men provided semen for testing, analyzed by quantitative reverse transcription PCR (qRT-PCR) for the presence of EBOV RNA. Follow-up occurred every 2 weeks until the endpoint, defined as 2 consecutive negative qRT-PCR results of semen specimen testing for EBOV RNA. Participants were matched with the Sierra Leone EVD case database to retrieve cycle threshold (Ct) values from the qRT-PCR analysis done in blood during acute disease. A purposive sampling strategy was used, and the included sample composition was compared to the national EVD survivor database to understand deviations from the general male survivor population. At 180 days (6 months) after Ebola treatment unit (ETU) discharge, the EBOV RNA semen positive rate was 75.4% (95% CI 66.9%\u201382.0%). The median persistence duration was 204 days, with 50% of men having cleared their semen of EBOV RNA after this time. At 270 days, persistence was 26.8% (95% CI 20.0%\u201334.2%), and at 360 days, 6.0% (95% CI 3.1%\u201310.2%). Longer persistence was significantly associated with severe acute disease, with probability of persistence in this population at 1 year at 10.1% (95% CI 4.6%\u201319.8%) compared to the probability approaching 0% for those with mild acute disease. Age showed a dose\u2013response pattern, where the youngest men (\u226425 years) were 3.17 (95% CI 1.60, 6.29) times more likely to be EBOV RNA negative in semen, and men aged 26\u201335 years were 1.85 (95% CI 1.04, 3.28) times more likely to be negative, than men aged &gt;35 years. Among participants with both severe acute EVD and a higher age (&gt;35 years), persistence remained above 20% (95% CI 6.0%\u201350.6%) at 1 year. Uptake of safe sex recommendations 3 months after ETU discharge was low among a third of survivors. The sample was largely representative of male survivors in Sierra Leone. A limitation of this study is the lack of knowledge about infectiousness.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In this study we observed that EBOV RNA persistence in semen was a frequent phenomenon, with high population rates over time. This finding will inform forthcoming updated recommendations on risk reduction strategies relating to sexual transmission of EBOV. Our findings support implementation of a semen testing program as part of epidemic preparedness and response. Further, the results will enable planning of the magnitude of testing and targeted counseling needs over time.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pmed.1003273","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T19:58:33Z","timestamp":1612987113000},"page":"e1003273","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":90,"title":["Persistence of Ebola virus in semen among Ebola virus disease survivors in Sierra Leone: A cohort study of frequency, duration, and risk factors"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8703-6561","authenticated-orcid":true,"given":"A. E.","family":"Thorson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. F.","family":"Deen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8455-899X","authenticated-orcid":true,"given":"K. T.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. J.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-5745","authenticated-orcid":true,"given":"F.","family":"Yamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4882-1687","authenticated-orcid":true,"given":"N.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7813-9526","authenticated-orcid":true,"given":"F. R.","family":"Sesay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7829-7620","authenticated-orcid":true,"given":"T. A.","family":"Massaquoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2363-2812","authenticated-orcid":true,"given":"S. L. R.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1456-626X","authenticated-orcid":true,"given":"K. N.","family":"Durski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Singaravelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9503-2475","authenticated-orcid":true,"given":"E.","family":"Ervin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9853-5294","authenticated-orcid":true,"given":"A.","family":"Coursier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Marrinan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0242-0186","authenticated-orcid":true,"given":"A.","family":"Ariyarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-2075","authenticated-orcid":true,"given":"M.","family":"Carino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-5411","authenticated-orcid":true,"given":"P.","family":"Formenty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Str\u00f6her","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lamunu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3000-5032","authenticated-orcid":true,"given":"B.","family":"Knust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3665-4861","authenticated-orcid":true,"given":"N.","family":"Broutet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Sierra Leone Ebola Virus Persistence Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"pmed.1003273.ref001","author":"World Health Organization","year":"2016"},{"key":"pmed.1003273.ref002","volume-title":"United Nations Development Group\u2013Western and Central Africa","year":"2015"},{"key":"pmed.1003273.ref003","volume-title":"Socio-economic impacts of Ebola on Africa","author":"United Nations Economic Commission for Africa","year":"2015"},{"issue":"2","key":"pmed.1003273.ref004","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3201\/eid2502.181011","article-title":"Ebola virus infection associated with transmission from survivors","volume":"25","author":"S Den Boon","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"17","key":"pmed.1003273.ref005","first-page":"479","article-title":"Possible sexual transmission of Ebola virus\u2014Liberia, 2015","volume":"64","author":"A Christie","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"25","key":"pmed.1003273.ref006","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1509773","article-title":"Molecular evidence of sexual transmission of Ebola virus","volume":"373","author":"SE Mate","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"pmed.1003273.ref007","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/cid\/ciw601","article-title":"Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days","volume":"63","author":"B Diallo","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pmed.1003273.ref008","doi-asserted-by":"crossref","first-page":"e008859","DOI":"10.1136\/bmjopen-2015-008859","article-title":"Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations","volume":"6","author":"A Thorson","year":"2016","journal-title":"BMJ Open"},{"issue":"3","key":"pmed.1003273.ref009","doi-asserted-by":"crossref","first-page":"ofx155","DOI":"10.1093\/ofid\/ofx155","article-title":"Ebola virus ribonucleic acid detection in semen more than two years after resolution of acute Ebola virus infection","volume":"4","author":"WA Fischer","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"pmed.1003273.ref010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/v10120683","article-title":"Persistence and sexual transmission of filoviruses","volume":"10","author":"BG Schindell","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"pmed.1003273.ref011","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S2214-109X(16)30243-1","article-title":"Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study","volume":"5","author":"D Sissoko","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"10","key":"pmed.1003273.ref012","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1016\/S2214-109X(16)30175-9","article-title":"Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data","volume":"4","author":"MJ Soka","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"15","key":"pmed.1003273.ref013","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJMoa1511410","article-title":"Ebola RNA persistence in semen of ebola virus disease survivors\u2014final report","volume":"377","author":"GF Deen","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"pmed.1003273.ref014","doi-asserted-by":"crossref","first-page":"e0005723","DOI":"10.1371\/journal.pntd.0005723","article-title":"Implementation of a study to examine the persistence of Ebola virus in the body fluids of Ebola virus disease survivors in Sierra Leone: Methodology and lessons learned","volume":"11","author":"GF Deen","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pmed.1003273.ref015","doi-asserted-by":"crossref","first-page":"e0005827","DOI":"10.1371\/journal.pntd.0005827","article-title":"Development of risk reduction behavioral counseling for Ebola virus disease survivors enrolled in the Sierra Leone Ebola Virus Persistence Study, 2015\u20132016","volume":"11","author":"N Abad","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pmed.1003273.ref016","volume-title":"2014 Ebola virus emergency use authorizations: CDC Ebola virus VP40 real-time RT-PCR assay (CDC)\u2014March 2, 2015","author":"Centers for Disease Control and Prevention","year":"2021"},{"key":"pmed.1003273.ref017","volume-title":"Ebola virus NP real-time RT-PCR assay","author":"Centers for Disease Control and Prevention","year":"2016"},{"issue":"Suppl 3","key":"pmed.1003273.ref018","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1093\/infdis\/jiw296","article-title":"Ebola virus disease diagnostics, Sierra Leone: analysis of real-time reverse transcription-polymerase chain reaction values for clinical blood and oral swab specimens","volume":"214","author":"BR Erickson","year":"2016","journal-title":"J Infect Dis"},{"issue":"5","key":"pmed.1003273.ref019","doi-asserted-by":"crossref","first-page":"e0005570","DOI":"10.1371\/journal.pntd.0005570","article-title":"External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014\u20132016 Ebola outbreak in West Africa","volume":"11","author":"H Ellerbrok","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pmed.1003273.ref020","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.celrep.2018.01.008","article-title":"Active Ebola virus replication and heterogeneous evolutionary rates in EVD survivors","volume":"22","author":"SLM Whitmer","year":"2018","journal-title":"Cell Rep"},{"issue":"12","key":"pmed.1003273.ref021","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/infdis\/jix236","article-title":"Development, use, and impact of a global laboratory database during the 2014 Ebola outbreak in West Africa","volume":"215","author":"KN Durski","year":"2017","journal-title":"J Infect Dis"},{"issue":"12","key":"pmed.1003273.ref022","doi-asserted-by":"crossref","first-page":"e1001908","DOI":"10.1371\/journal.pmed.1001908","article-title":"Use of viremia to evaluate the baseline case fatality ratio of Ebola virus disease and inform treatment studies: a retrospective cohort study","volume":"12","author":"O Faye","year":"2015","journal-title":"PLoS Med"},{"key":"pmed.1003273.ref023","volume-title":"SAS system for Windows, release 9.4","year":"2014"},{"key":"pmed.1003273.ref024","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3115-3","volume-title":"Modelling survival data in medical research","author":"D. Collett","year":"1994"},{"issue":"12","key":"pmed.1003273.ref025","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/cid\/cix210","article-title":"Dynamics of Ebola RNA persistence in semen: a report from the Postebogui Cohort in Guinea","volume":"64","author":"F Subtil","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"pmed.1003273.ref026","doi-asserted-by":"crossref","first-page":"ofz482","DOI":"10.1093\/ofid\/ofz482","article-title":"A 40-month follow-up of Ebola virus disease survivors in Guinea (PostEbogui) reveals long-term detection of Ebola viral ribonucleic acid in semen and breast milk","volume":"6","author":"AK Keita","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"pmed.1003273.ref027","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805435","article-title":"a longitudinal study of ebola sequelae in Liberia","volume":"380","author":"PIS Group","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"pmed.1003273.ref028","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/infdis\/jiw078","article-title":"New evidence of long-lasting persistence of Ebola virus genetic material in semen of survivors","volume":"214","author":"MS Sow","year":"2016","journal-title":"J Infect Dis"},{"issue":"12","key":"pmed.1003273.ref029","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/cid\/ciw202","article-title":"Ebola virus persistence in semen of male survivors","volume":"62","author":"TM Uyeki","year":"2016","journal-title":"Clin Infect Dis"},{"key":"pmed.1003273.ref030","volume-title":"Ebola virus disease Democratic Republic of Congo: external situation report 89","author":"World Health Organization","year":"2020"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T19:58:53Z","timestamp":1612987133000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003273"}},"subtitle":[],"editor":[{"given":"Jason","family":"Kindrachuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003273","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]}}}